BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies

Trial Profile

BENEFIT 15 long-term follow-up study of the BENEFIT and BENEFIT follow-up studies

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2018

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms BENEFIT 15
  • Sponsors Bayer
  • Most Recent Events

    • 08 Jan 2018 Planned primary completion date changed from 30 Mar 2018 to 28 Feb 2018.
    • 07 Dec 2017 Status has been changed from not yet Recruiting to Recruiting
    • 12 Sep 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top